Brucellosis: A re-emerging zoonosis

被引:513
作者
Seleem, Mohamed N. [1 ,2 ]
Boyle, Stephen M. [1 ]
Sriranganathan, Nammalwar [1 ]
机构
[1] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Ctr Mol Med & Infect Dis, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA
[2] Virginia Polytech Inst & State Univ, Inst Crit Technol & Appl Sci, Blacksburg, VA 24061 USA
关键词
Brucella; Zoonosis; LABORATORY-ACQUIRED BRUCELLOSIS; DOXYCYCLINE PLUS STREPTOMYCIN; MELITENSIS INFECTION; AGGLUTINATION-TEST; GENOME SEQUENCE; B-MELITENSIS; GOATS; ABORTUS; TRANSMISSION; DIAGNOSIS;
D O I
10.1016/j.vetmic.2009.06.021
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Brucellosis, especially caused by Brucella melitensis, remains one of the most common zoonotic diseases worldwide with more than 500,000 human cases reported annually. The bacterial pathogen is classified by the CDC as a category (B) pathogen that has potential for development as a bio-weapon. Brucella spp. are considered as the most common laboratory-acquired pathogens. The geographical distribution of brucellosis is constantly changing with new foci emerging or re-emerging. The disease occurs worldwide in both animals and humans, except in those countries where bovine brucellosis has been eradicated. The worldwide economic losses due to brucellosis are extensive not only in animal production but also in human health. Although a number of successful vaccines are being used for immunization of animals, no satisfactory vaccine against human brucellosis is available. When the incidence of brucellosis is controlled in the animal reservoirs, there is a corresponding and significant decline in the incidence in humans. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:392 / 398
页数:7
相关论文
共 64 条
[1]  
Acha NP., 2003, Zoonoses and communicable diseases common to man and animals, V1
[2]   Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B-melitensis and B-ovis infections [J].
Adone, R. ;
Francia, M. ;
Ciuchini, F. .
VACCINE, 2008, 26 (38) :4913-4917
[3]   Changing epidemiology of human brucellosis, Germany, 1962-2005 [J].
Al Dahouk, Sascha ;
Neubauer, Heinrich ;
Hensel, Andreas ;
Schoeneberg, Irene ;
Noeckler, Karsten ;
Alpers, Katharina ;
Merzenich, Hiltrud ;
Stark, Klaus ;
Jansen, Andreas .
EMERGING INFECTIOUS DISEASES, 2007, 13 (12) :1895-1900
[4]   Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647] [J].
Alp, E ;
Koc, RK ;
Durak, AC ;
Yildiz, O ;
Aygen, B ;
Sumerkan, B ;
Doganay, M .
BMC INFECTIOUS DISEASES, 2006, 6 (1)
[5]  
[Anonymous], 2000, J AM VET MED ASSOC, V216, P648
[6]   TREATMENT OF HUMAN BRUCELLOSIS WITH DOXYCYCLINE PLUS RIFAMPIN OR DOXYCYCLINE PLUS STREPTOMYCIN - A RANDOMIZED, DOUBLE-BLIND-STUDY [J].
ARIZA, J ;
GUDIOL, F ;
PALLARES, R ;
VILADRICH, PF ;
RUFI, G ;
CORREDOIRA, J ;
MIRAVITLLES, MR .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (01) :25-30
[7]   Probable transmission of brucellosis by breast milk [J].
Arroyo Carrera, Ignacio ;
Lopez Rodriguez, Maria Jose ;
Martinez Sapina, Ana ;
Lopez Lafuente, Amparo ;
Barrio Sacristan, Ana Raquel .
JOURNAL OF TROPICAL PEDIATRICS, 2006, 52 (05) :380-381
[8]   A review of the use of B-melitensis Rev 1 vaccine in adult sheep and goats [J].
Blasco, JM .
PREVENTIVE VETERINARY MEDICINE, 1997, 31 (3-4) :275-283
[9]   Laboratory-acquired brucellosis:: a Spanish national survey [J].
Bouza, E ;
Sánchez-Carrillo, C ;
Hernangómez, S ;
González, MJ .
JOURNAL OF HOSPITAL INFECTION, 2005, 61 (01) :80-83
[10]  
Brew SD, 1999, VET REC, V144, P483